You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

April 10, 2018

Vietnam: Does Subsequent Cancellation of a Patent Justify a Retrial?

Managing Intellectual Property

In the Vietnamese judicial system, there are two avenues for reviewing a court’s final judgment. Under the current procedural legislation, if such judgment can be shown to be based on a serious error of law, it can go through the process of cassation, where the judgment will be reviewed and possibly annulled due to the material error in the procedures. If, on the other hand, new evidence or facts are discovered that could have affected the outcome of the case, the case can be retried.

Recently, the Supreme People’s Court applied the procedure of retrial to a 2011 patent infringement case following the cancellation of the patent in question, a decision that could set an interesting precedent for future intellectual property disputes.

In this case, which involved a Vietnamese company’s utility solution patent for a shaped aluminum bar, the People’s Court of Ho Chi Minh City had issued a first-instance judgment in favor of the plaintiff, requesting the defendant to make a public apology and pay damages for its infringement of the patent. The appellate court then denied the defendant’s appeal in a June 2012 decision and upheld the first-instance judgment.

An appellate verdict is considered an effective final judgment and, in principle, closes the process of hearing a case. However, in this case, an unexpected situation arose when the utility solution patent was canceled by the National Office of Intellectual Property (NOIP) seven months later, in January 2013. After the cancellation, the defendant filed a petition requesting the court to review the case under the procedure of retrial.

The Supreme People’s Court ruled, in a 2016 decision that was only recently made public, that the case should be retried. The decision did not provide any analysis or guidance, but it appears that the Supreme People’s Court automatically considered the cancellation of the patent as a “new fact” and thus canceled the entire first-instance judgment as well as the appellate verdict, handing the case back to the first-instance court for retrial.

This decision was unexpected, and raises questions about the proper interpretation of the law. The key issue is whether the subsequent cancellation of the patent in question, which had been fully effective at the time of the first-instance and appellate trials, should be regarded as a “new fact” which the court could rely on to approve a retrial.

Pursuant to Article 304 of the 2004 Civil Procedure Code (which was still valid at the time of the first-instance and appellate trials, as well as the time the retrial was ordered), the grounds for retrying a case must be a newly discovered fact which the court and the involved parties were unaware of when the court issued the judgment or ruling. The term “discover” here would seem to indicate that this fact must have inherently existed at the time of the original trial, and not have occurred subsequently. In this case, however, the parties were not aware of such new fact because the fact did not exist until after the judgment took effect. Nevertheless, the Supreme People’s Court held that the patent cancellation was valid grounds for a retrial.

While the Supreme People’s Court’s decision in this case has not yet been widely discussed, it could end up having a major impact on the settlement of IP cases if it serves as a precedent. Vietnam does not have a system of specialized IP courts; thus, in principle, despite many judges lacking deep legal and technical knowledge in IP, any court can be given jurisdiction over an IP case, whether such case is simple or extremely complicated. It is likely that the courts will give more weight to NOIP invalidation proceedings when settling IP disputes, to avoid potential reversal of the final judgments. Some courts may even stay the infringement proceedings pending the final outcomes of the nullity process before the NOIP, as happened recently in a case before the Binh Duong provincial court involving the infringement of a pharmaceutical patent.

The NOIP, unfortunately, is not known for its timeliness in settling patent cancellations. The process may take years, and in some cases there might never be a final decision. If the courts insist on waiting for cancellation decisions before issuing judgments in IP dispute cases, the plaintiffs may face a very long wait indeed. Further clarification is needed on this matter, and invalidation proceedings at the NOIP should be fast-tracked, to ensure that IP owners’ rights are protected.

RELATED INSIGHTS​ 

June 24, 2026
Patent enablement requirements are provided under Article 102 of Vietnam’s Law on Intellectual Property (IP Law). In particular, a patent specification must “fully and clearly disclose the nature of the invention to such an extent that, based on the specification, a person having ordinary skill in the relevant art can implement the invention.” In pharmaceutical and biotechnology patents, this requirement is more complicated and subject to more rigorous assessment. The Patent Examination Guidelines (Guidelines) of the Intellectual Property Office of Vietnam (IP Office) were amended in March 2026 to introduce Annexes III and IV for the pharmaceutical and biotechnology sectors, in which Annex III provides detailed guidelines on the assessment of specification requirements. These amendments were made under a project for strengthening capacity in industrial property examination between the Japan International Cooperation Agency (JICA) and the IP Office. Annex III provides detailed instructions on how examiners assess enablement in a pharmaceutical or biotechnology application, and offers examples of acceptable and unacceptable descriptions with regard to the enablement aspect. Enablement Requirements in Pharma and Biotech Patents Article 12.7 of Circular 10/2026/TT-BKHCN (Circular 10) adds to the requirements of Article 102 of the IP Law that the description must demonstrate the novelty, inventive step, and industrial applicability of the technical solution. For pharmaceutical composition subject matters, Article 12.9 of Circular 10 sets out that the description must present the results of clinical trials and/or the pharmacological effects of the claimed pharmaceutical composition, and must include at least the following information: Substance/mixture used. Testing method (system) employed. Information on the test results. Correlation between the pharmacological effects obtained from the tests and the application of the pharmaceutical product in the prevention, diagnosis, and treatment of diseases. The Guidelines note that pharmacological study results should be presented in a quantified manner, and pharmacological
June 16, 2026
Since the implementation of the Trademark Law 2019 on April 1, 2023, Myanmar has operated under a modern first-to-file trademark system that brings its registration framework closer to international practice. As the new regime continues to develop in practice, applicants are increasingly required to navigate formal examination requirements, substantive objections, and procedural deadlines with greater precision. This article provides a high-level review of the trademark examination process in Myanmar, focusing on the principal stages from initial review to approval, the types of objections commonly raised by the Intellectual Property Department (IPD), and the key considerations for responding effectively. A clear understanding of these issues is essential for applicants seeking to secure registration efficiently and to mitigate avoidable delays or refusals. Examination Process: Key Stages Trademark applications filed with the IPD undergo two stages of review. Formality Examination The IPD first verifies compliance with procedural requirements, including: Correct Nice Classification Clear mark representation Accurate applicant details Clearly defined goods or services Representative details, if the application is filed by a representative Other formality requirements cover translation and transliteration of any non-English or non-Myanmar elements in the mark, color claim details, applicable disclaimers, and payment of official fees. Deficiencies result in an office action requiring correction within 30 days, which may be extended upon request. Registrability Examination The IPD also assesses registrability. A mark may be refused if it: Lacks distinctiveness Is descriptive or generic Misleads the public or violates public order/morality Contains prohibited state symbols Only compliant applications proceed to publication. Responding to Office Actions Applicants must respond within 30 days of notification from the IPD. Depending on the nature of the objection, strategies may include submitting legal arguments for distinctiveness, providing evidence of acquired distinctiveness, filing appropriate disclaimers, clarifying descriptions such as color claims, or amending the listed goods
June 15, 2026
The surge in AI development has led to a desperate demand for large, high-quality training data. However, real-world data can be expensive to collect, difficult to access, and often subject to strict privacy and regulatory constraints. Synthetic data, which consists of artificially generated records that replicate the statistical properties of real-world data without reproducing specific individuals’ information, provides an appealing solution by generating artificial datasets at scale without relying on identifiable personal information. It combines speed, cost efficiency, and regulatory compliance, making it a sensible alternative for organizations seeking to reduce risks while maintaining data utility. When properly anonymized, synthetic datasets may fall outside the scope of laws such as the EU’s General Data Protection Regulation (GDPR) or Thailand’s Personal Data Protection Act (PDPA), reducing compliance burdens while still supporting high-quality model training. However, relying on synthetic data without rigorous legal due diligence could be a strategic mistake. It replaces one set of known risks (scraping, direct privacy liability) with a new set of complex liabilities. The narrative that synthetic data is a “silver bullet” for privacy and IP compliance is dangerous and could be misleading. While synthetic data addresses data scarcity, it also introduces new legal uncertainties. Legal counsel should anticipate downstream risks arising from compromised data sources. Models trained on unlawfully obtained data may need to be decommissioned, even if their outputs appear lawful. What is synthetic data? Synthetic data refers to artificially generated information created using AI techniques such as deep learning and generative models. Instead of copying real records, it reproduces the statistical patterns and relationships found in the original dataset. Synthetic data generally falls into three categories: Fully synthetic data – Entirely new data points generated from learned patterns. The model studies the structure of the original data and produces records that resemble real-world
June 10, 2026
In March 2026, the Intellectual Property Office of Vietnam (IP Office) issued a decision refusing a trademark application after considering an opposition based primarily on copyright grounds. The outcome is noteworthy because the foreign brand owner had neither trademark registrations nor applications in Vietnam at the time the opposition was filed, and the IP Office has historically applied a stringent approach to oppositions relying on copyright. The Opposition Maurten is a well-known Swedish sports nutrition brand recognized globally for its innovative hydrogel technology, which is designed to help endurance athletes fuel more effectively without gastrointestinal discomfort. The brand’s distinctive logo is characterized by clean lines and a bold black-and-white color scheme, and has long been associated with the company’s performance products. The brand’s logo is displayed above. An identical mark was filed for registration by a Vietnamese trademark squatter. In 2023, a Vietnamese individual filed an application for registration of an identical mark (Application No. 4-2023-38668), a practice commonly observed in Vietnam as trademark squatting. The brand owner engaged Tilleke & Gibbins to assist with strategy and filing an opposition to the mark. At the time, Maurten had no trademark rights or meaningful use in Vietnam, and global marketing data showed only modest figures without any local presence. Thus, to convince the IP Office to refuse the squatter’s application, instead of relying on trademark rights or use evidence, the opposition strategy centered on the copyright protection of the logo itself, as copyright arises automatically in Vietnam upon creation of the work and does not require registration. (It is worth noting, however, that the IP Office has traditionally been cautious in accepting copyright as a basis for refusing trademark applications.) On September 24, 2024, an opposition was filed on three main grounds: confusing similarity, copyright infringement of the artistic work,